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Implications for the Advanced Practice Nurse
§ Assess	and	intervene	on	modifiable	variables	r/t	medication	regimens	starting	with	inpatient	initiation	of	pharmacological	
interventions		®cost,	knowledge	deficit/depression/mental	health	(Albert	&	Kozinn,	2018)
§ Lead	HF	clinics	utilizing	a	multidisciplinary	approach	®patients	will	reach	optimization	in	pharmacological	therapies	and	remain	
adherent
§ Evaluate	need	for	implantable	cardiac	defibrillator	(ICD)	placement	®placement	post-cardiac	injury	with	a	rEF reduces	mortality	
(Chan	et	al.,	2020)
§ Telehealth	visits	®assess	symptoms	to	avoid	rapid	decompensation
§ Evaluate	need	for	invasive/noninvasive	monitoring	devices	® assess	impeding	decompensation	(Murphy	et	al.,	2019)
§ LVAD-education	on	expectations/risks	and	complications/effects	on	QoL/palliative	care	(Kaiser,	2019)
*LAST	TREATMENT	OPTION	FOR	HFrEF/NOT	ELIGIBLE	FOR	TRANSPLANT*
Conclusion
HFrEF is	a	chronic	disease	in	which	
treatment	is	constantly	evolving.	
The	pathophysiology	of	the	disease	
and	ways	to	effectively	manage	
HFrEF are	everchanging.	Hence,	
research	continues	on	the	molecular	
changes	that	occur	within	the	heart	
as	well	as	appropriate	therapies	for	
disease	management.	The	APN	is	in	
a	front-line	role	to	educate	patients	
and	initiate	therapies	to	prevent	
readmissions.	APN	led	HF	clinics	are	
beneficial	in	ensuring	faster	follow-
up	after	discharge.	Knowledge	
sharing	between	the	APN	and	
patient	can	increase	the	patient	with	
HFrEF adherence	and	quality	of	life.	
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